Does LEMBOREXANT Cause Off label use? 45 Reports in FDA Database
Wake Up Pain-Free — Sleep Like Never Before
Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Off label use have been filed in association with LEMBOREXANT (DAYVIGO). This represents 4.6% of all adverse event reports for LEMBOREXANT.
45
Reports of Off label use with LEMBOREXANT
4.6%
of all LEMBOREXANT reports
1
Deaths
31
Hospitalizations
How Dangerous Is Off label use From LEMBOREXANT?
Of the 45 reports, 1 (2.2%) resulted in death, 31 (68.9%) required hospitalization, and 3 (6.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEMBOREXANT. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does LEMBOREXANT Cause?
Drug ineffective (225)
Suicide attempt (98)
Somnolence (90)
Suicidal ideation (86)
Sleep paralysis (80)
Condition aggravated (74)
Nightmare (71)
Altered state of consciousness (45)
Adverse drug reaction (44)
Headache (43)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which LEMBOREXANT Alternatives Have Lower Off label use Risk?
LEMBOREXANT vs LENACAPAVIR
LEMBOREXANT vs LENALIDOMIDE
LEMBOREXANT vs LENIOLISIB
LEMBOREXANT vs LENOGRASTIM
LEMBOREXANT vs LENVATINIB